National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 3,619 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died

Government Disclaimer on use of this data



Case Details (Sorted by Age)

This is page 24 out of 362

Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next


VAERS ID: 1133429 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-09
Onset:2021-02-13
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0725 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-21
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210213; Test Name: body temperature; Result Unstructured Data: Test Result:37.5 Centigrade; Test Date: 20210213; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ITPFIZER INC2021297543

Write-up: drug ineffective; positive molecular swab/fever 37.5 � c; This is a spontaneous report from contactable physician downloaded from the Regulatory authority-WEB regulatory authority IT-MINISAL02-697594. A 92-years-old female patient received the first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 19Jan2021 at single dose, and the second dose (Batch/Lot Number: EL0725; Expiration Date: 31Mar2021), via intramuscular administered in left arm on 09Feb2021 09:48 at 0.3 mL, single for COVID-19 vaccination. The patient medical history and concomitant medications were not reported. The patient experienced drug ineffective on 13Feb2021, positive molecular swab on 13Feb2021, fever 37.5 � c on 13Feb2021, admitted and died at the hospital on 21Feb2021. The patient underwent lab tests and procedures which included COVID-19 PCR test: Positive on 13Feb2021. The patient died on 21Feb2021. It was not reported if an autopsy was performed. Reporter comment: 1st dose taken on 19Jan2021. Positive molecular swab dated 13Feb2021. Admitted and died at the hospital on 21Feb Sender comment: 12Feb2021: the reporter contacted and the death clinical report requested. Stop date for events (21Feb2021) No follow-up attempts possible. No further information expected. Lot/Batch number already obtained.; Reported Cause(s) of Death: drug ineffective; positive molecular swab/fever 37.5 � c


VAERS ID: 1133438 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-02-12
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, COVID-19, Condition aggravated, Irritability, Malaise, Pain, Pneumonia, SARS-CoV-2 test, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-27
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arthralgia (used Medrol tablets occasionally for 15-20 years); Bronchial asthma (Lasts for 40 years); Hypertension (was used to higher systolic blood pressure); Obstructive bronchitis (Lasts for 40 years)
Allergies:
Diagnostic Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:160-180 mmHg; Test Name: blood pressure; Result Unstructured Data: Test Result:120 mmHg; Test Name: Covid-19 test; Test Result: Negative ; Test Date: 20210219; Test Name: Covid-19 test; Test Result: Positive
CDC Split Type: LTPFIZER INC2021298169

Write-up: Irritability; Heavy pain; Condition worsened; Pneumonia; Feeling unwell; vaccination failure; COVID-19 test was done, which turned out to be positive; This is a spontaneous report received from a contactable consumer downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is LT-SMCA-4011. An 81-years-old female patient received the first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date at single dose, and the second dose on 10Feb2021 at single dose for COVID-19 immunisation. Medical history included suffered from bronchial asthma and obstructive bronchitis lasts for 40 years, used unspecified inhaler occasionally; used methylprednisolone (Medrol) tablets occasionally for 15-20 years to treat arthralgia; hypertension and occasionally used unspecified medicines to treat it, was used to higher systolic blood pressure, she considered it to be normal at 160-180 mmHg and felt bad if it decreased to 120 mmHg. The patient''s concomitant medications were not reported. The patient experienced vaccination failure on 19Feb2021 with outcome of unknown. Clinical course reported as follow: Patient lived in nursery home for the latter (unspecified) period, vaccine was injected there. COVID-19 test done before the second dose was negative (exact date of the test was unknown). Patient experienced adverse reaction on 12 or 13Feb2021. Reaction was described generally as "feeling not well". Approximately on 15Feb2021 pneumonia was diagnosed. On 17Feb2021 patient started feeling quite bad. On 19Feb2021 she was hospitalized, COVID-19 test was done, which turned out to be positive. After that patient condition worsened (17Feb2021) every day. Oxygen mask was put on, morphine was given due to heavy pain (pain was not specified). Antibiotics were prescribed, infusions were given as well. Patient was irritated, tried to rip off the oxygen mask, asked physicians to let her die in peace, personally had to tie her hands to bed. Seriousness criteria was reported as death and hospitalization. Patient died on 27Feb2021. Autopsy was not done. Sender Comment: Physician who treated the patient in hospital to be contacted, report to be amended in case more details obtained. stop date of the events: 27Feb2021. No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.; Reported Cause(s) of Death: Heavy pain; pneumonia; Irritability; Feeling unwell; Condition worsened


VAERS ID: 1135088 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-17
Onset:2021-01-31
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0739 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-04
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210131; Test Name: COVID-19; Result Unstructured Data: Test Result:+ve
CDC Split Type: GBPFIZER INC2021304964

Write-up: SARS-CoV-2 infection/ COVID +ve; SARS-CoV-2 infection/ COVID +ve; This is a spontaneous report from a contactable physician. This is a report received from the Regulatory authority Regulatory authority report number: GB-MHRA-WEBCOVID-202103161715400580, Safety Report Unique Identifier: GB-MHRA-ADR 24958447. An 80-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL0739, Expiration Date: not reported) dose 1, via an unspecified route of administration on 17Jan2021 as single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient had not had symptoms associated with COVID-19, not had a COVID-19 test and was not enrolled in clinical trial. The patient experienced sars-cov-2 infection on 31Jan2021. The patient was hospitalized for sars-cov-2 infection from 31Jan2021. Admitted to hospital via ambulance on 31Jan2021 and confirmed COVID +ve. The case was reported as death, hospitalization, medically significant. The patient underwent lab tests and procedures which included COVID +ve on 31Jan2021. The outcome was fatal. The patient died on 04Feb2021. It was not reported if an autopsy was performed and the reported cause of death was SARS-CoV-2 infection. No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: SARS-CoV-2 infection/ COVID +ve; SARS-CoV-2 infection


VAERS ID: 1140571 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-02-25
Submitted: 0000-00-00
Entered: 2021-03-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Cardiac failure, Chronic obstructive pulmonary disease, Computerised tomogram thorax, Drug ineffective, Dyspnoea exertional, Investigation, Procalcitonin, Productive cough, Renal failure, Respiratory failure, SARS-CoV-2 antibody test, SARS-CoV-2 test
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Cardiac failure (narrow), Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Chronic kidney disease (narrow), Hypersensitivity (broad), Tumour lysis syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-06
   Days after onset: 9
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: RAMIPRIL; SYMBICORT
Current Illness: Asbestosis; Hypertension arterial; Prostatectomy
Preexisting Conditions: Medical History/Concurrent Conditions: Adenocarcinoma of prostate; COPD; Drug allergy (allergy to beta lactams)
Allergies:
Diagnostic Lab Data: Test Date: 20210302; Test Name: thoracic CT scan; Result Unstructured Data: Test Result:pulmonary emphysema. Bilateral pleural abnormaliti; Comments: pulmonary emphysema. Bilateral pleural abnormalities more marked on the left, with retractive parenchymal changes in the form of crow''s feet and probable left basal coil atelectasis. No pulmonary embolism.; Test Date: 202103; Test Name: infectious samples (multiplex PCR PAVM (Pulmonary Arteriovenous Malformations); Result Unstructured Data: Test Result:negativity; Test Date: 202103; Test Name: procalcitonin test; Result Unstructured Data: Test Result:negativity; Test Name: Anti-SARS -CoV- 2 serology; Result Unstructured Data: Test Result:COVID 19 IgM equivocal; Test Name: Anti-SARS -CoV- 2 serology; Result Unstructured Data: Test Result:IgG Spike positive; Test Name: Anti-SARS -CoV- 2 serology; Result Unstructured Data: Test Result:IgG capsid negative; Test Date: 20210301; Test Name: PCR COVID-19 on nasopharyngeal swab; Result Unstructured Data: Test Result:positive for variant
CDC Split Type: FRPFIZER INC2021312123

Write-up: COVID-19 aggravated; COVID-19 aggravated; renal failure; Increased oxygen dependence; probable cardiac decompensation; Dyspnoea/dyspnea on exertion; Cough/cough with purulent sputum; COPD exacerbation; This is a spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is FR-AFSSAPS-RN20210757. A 92-year-old male patient received bnt162b2 (COMIRNATY, lot number unknown), dose 1 via an unspecified route of administration on an unspecified date as single dose and dose 2 intramuscular (vaccinated limb unknown) on 23Feb2021 as single dose for covid-19 immunisation. Medical history included ongoing hypertension arterial, prostate adenocarcinoma resected in 2019, adenocarcinoma of prostate from 2019 and unknown if ongoing, drug allergy (allergy to beta lactams) from an unspecified date and unknown if ongoing, ongoing asbestosis, chronic obstructive pulmonary disease (COPD) ) from an unspecified date and unknown if ongoing. The patient has no history of COVID-19. Concomitant medications included long-term with ramipril; budesonide, formoterol fumarate (SYMBICORT) and monthly homeopathy. The patient experienced dyspnoe and cough on 25Feb2021, COVID-19 aggravated on 01Mar202, COPD exacerbation in 2021, renal failure, increased oxygen dependence and probable cardiac decompensation in Mar2021. Clinical course: The patient presented on 25Feb2021 with cough with purulent sputum and dyspnea on exertion. Faced with an increase in symptoms, emergency consultation was on 01Mar2021. PCR (Polymerase Chain Reaction) COVID-19 on 01Mar2021 on nasopharyngeal swab: positive for variant. Anti-SARS -CoV- 2 serology on an unspecified date: COVID 19 IgM equivocal; IgG Spike positive; IgG capsid negative. In view of the underlying asbestos terrain with chronic obstructive pulmonary disease (COPD) and allergy to beta-lactam antibiotics, introduction of antibiotic therapy with pristinamycin (PYOSTACIN) 1g 3/d for 5 days in view of a possible bacterial superinfection and COPD exacerbation. Progressive increase in oxygen dependence leading to a thoracic CT scan (injected on 02Mar2021) with 46% of the patient affected. Underlying pathological lung: pulmonary emphysema. Bilateral pleural abnormalities more marked on the left, with retractive parenchymal changes in the form of crow''s feet and probable left basal coil atelectasis. No pulmonary embolism. Introduction of dexamethasone 10 mg/d IV on 03Mar2021 following an infectious disease opinion in view of the low probability of bacterial superinfection given the absence of a radiological focus and the negativity of infectious samples (multiplex PCR PAVM (Pulmonary Arteriovenous Malformations), antigenuries, PCT (procalcitonin test)) in Mar2021. Maintenance of moderate hydration in the presence of renal failure and the cardiac impact of pneumopathy. At D3 of dexamethasone, introduction of tocilizumab on 05Mar2021 in the presence of oxygen dependence at 6L/min. Increased oxygen dependence and probable cardiac decompensation without response to diuretic therapy leading to the patient''s death on 06Mar2021 at 5:20 am. CONCLUSION: Death from documented SARS Cov 2 (variant) infection in a setting of asbestos pathology and chronic obstructive pulmonary disease. The patient died on 06Mar2021. It was not reported if an autopsy was performed. Outcome of all events were fatal. No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Increased oxygen dependence; probable cardiac decompensation; COVID-19 aggravated; renal failure; COVID-19 aggravated; Cough/cough with purulent sputum; Dyspnoea/dyspnea on exertion; chronic obstructive pulmonary disease/COPD exacerbation


VAERS ID: 1140573 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-10
Onset:2021-03-11
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9605 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Auscultation, Blood bicarbonate, Blood electrolytes, Blood pH, Body temperature, Bronchitis, C-reactive protein, COVID-19, Cardiovascular examination, Coma scale, Computerised tomogram thorax, Decreased appetite, Dyspnoea, Gastrointestinal examination, Hyperleukocytosis, Investigation, Ischaemic stroke, Neutrophil count, Neutrophil count increased, Oxygen saturation, Oxygen saturation decreased, PCO2, PO2, Platelet count, Pneumonitis, Pyrexia, Renal function test, Respiratory rate, SARS-CoV-2 test, Scan brain, Thrombocytopenia, White blood cell count
SMQs:, Anaphylactic reaction (broad), Haematopoietic thrombocytopenia (narrow), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Malignancy related conditions (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (narrow), Hypersensitivity (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-12
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PARACETAMOL; NEBIVOLOL; AMLODIPINE BESILATE; CLOPIDOGREL; LEVOTHYROX; PRAVASTATIN; CALCIDOSE VITAMINE D; LORAZEPAM; PAROXETINE
Current Illness: Speech disorder
Preexisting Conditions: Medical History/Concurrent Conditions: Appendectomy; C-section; Carcinoma of tongue; Coronary bypass; CVA; Hyperlipidemia; Penicillin allergy
Allergies:
Diagnostic Lab Data: Test Date: 20210311; Test Name: pulmonary auscultation; Result Unstructured Data: Test Result:some crackles; Comments: some crackles in the right base, decrease in vesicular murmur on the left. Supra-clavicular pull, thoraco-abdominal swing; Test Date: 20210312; Test Name: pulmonary auscultation; Result Unstructured Data: Test Result:bilateral crackles; Test Date: 20210311; Test Name: bicarbonates; Result Unstructured Data: Test Result:21.7 mmol/L; Test Date: 20210312; Test Name: blood ionogram; Result Unstructured Data: Test Result:Normal; Test Date: 20210311; Test Name: blood pH; Result Unstructured Data: Test Result:7.44; Test Date: 20210311; Test Name: body temperature; Result Unstructured Data: Test Result:39.5 Centigrade; Test Date: 20210311; Test Name: Cardiovascular; Result Unstructured Data: Test Result:regular heart sounds, no murmur; no IMO; Comments: regular heart sounds, no murmur; no IMO, no jugular turgor; soft, painless calves; Test Date: 20210312; Test Name: Glasgow; Result Unstructured Data: Test Result:3; Test Date: 20210311; Test Name: CHEST CT; Result Unstructured Data: Test Result:no detectable acute proximal pulmonary embolism; Comments: Atypical bilateral pneumonitis, potentially suggestive of COVID involvement (moderate relaxation), with probable superinfection of bronchial origin within the left upper lobe; Test Date: 20210311; Test Name: C-reaktive protein; Result Unstructured Data: Test Result:2.5 mg/l; Test Date: 20210311; Test Name: Abdomen; Result Unstructured Data: Test Result:soft, depressible, tender in the epigastric region; Test Date: 20210311; Test Name: fractional shortening; Result Unstructured Data: Test Result:56; Comments: /min; Test Date: 20210311; Test Name: neutrophils; Result Unstructured Data: Test Result:10.42; Comments: G/L; Test Date: 20210311; Test Name: oxygen saturation; Test Result: 95 %; Test Date: 20210312; Test Name: oxygen saturation; Test Result: 82 %; Test Date: 20210311; Test Name: PCO2; Result Unstructured Data: Test Result:32 mmHg; Test Date: 20210311; Test Name: thrombocytes; Result Unstructured Data: Test Result:90; Comments: G/L; Test Date: 20210311; Test Name: PO2; Result Unstructured Data: Test Result:66 mmHg; Test Date: 20210312; Test Name: renal function; Result Unstructured Data: Test Result:normal; Test Date: 20210311; Test Name: respiratory rate; Result Unstructured Data: Test Result:40; Comments: /min; Test Date: 20210311; Test Name: SARS-CoV-2 PCR test; Test Result: Negative ; Test Date: 20210311; Test Name: brain scan; Result Unstructured Data: Test Result:acute constituted ischemic focus; Comments: systematized left frontal hypodensity suggesting an acute constituted ischemic focus; Test Date: 20210312; Test Name: brain scan; Result Unstructured Data: Test Result:systematized left frontal hypodensity; Test Date: 20210311; Test Name: wbc; Result Unstructured Data: Test Result:11.29; Comments: G/L
CDC Split Type: FRPFIZER INC2021311863

Write-up: Dyspnoea; Fever; Ischemic stroke; Saturation at 82%; Atypical bilateral pneumonitis; probable superinfection of bronchial origin within the left upper lobe; COVID-19; 10.42 G/L of PNN (neutrophils); did not eat all day; hyperleukocytosis 11.29 G/L; thrombocytopenia 90 G/L; This is a spontaneous report received from a contactable physician downloaded from the Regulatory Authority (RA). The regulatory authority report number is FR-AFSSAPS-RS20210427. An 86-year-old female patient received the first dose of bnt162b2 (COMIRNATY; Lot Number: EP9605) intramuscular, administered in Arm Right, on 10Mar2021, as SINGLE DOSE for covid-19 immunisation. Medical history included cerebrovascular accident from 2020 to an unknown date, coronary artery bypass from an unknown date and unknown if ongoing, Penicillin allergy from an unknown date and unknown if ongoing, hyperlipidaemia from an unknown date and unknown if ongoing, caesarean section, Appendectomy, Carcinoma of tongue from an unknown date and unknown if ongoing, and ongoing significant speech problems. Concomitant medications included paracetamol, nebivolol, amlodipine besilate, clopidogrel, levothyroxine sodium (LEVOTHYROX), pravastatin, calcium carbonate, colecalciferol (CALCIDOSE VITAMINE D), lorazepam, and paroxetine. On 11Mar2021, emergency services was alerted by neighbours who have not seen the patient during the day. Patient found lying in bed, dyspneic, febrile, did not eat all day. On arrival of the emergency services, the patient was congested, saturated 95% AA (Amino Acids), febrile 39.5 C, FR (fractional shortening) 56/min. She was hospitalised. Questioning was not very helpful, significant speech problems since an operation for tongue cancer. According to her daughter-in-law, patient is usually comprehensible. Emergency examination: pulmonary auscultation: some crackles in the right base, decrease in vesicular murmur on the left. Supra-clavicular pull, thoraco-abdominal swing. Polypneic 40/min. Cardiovascular: regular heart sounds, no murmur; no IMO, no jugular turgor; soft, painless calves. Abdomen soft, depressible, tender in the epigastric region. Biology: hyperleukocytosis 11.29 G/L including 10.42 G/L of PNN (neutrophils); thrombocytopenia 90 G/L. Normal blood ionogram, normal renal function. CRP (C-reactive protein) (< 342.0mg/l) = 2.5, ABG (arterial blood gases): pH 7.44; PO2 (partial pressure of oxygen) 66 mmHg, PCO2 (partial pressure of carbon dioxide) 32 mmHg, bicarbonates 21.7 mmol/l; COVID PCR (Polymerase chain reaction) negative. Chest CT: no detectable acute proximal pulmonary embolism within the limits of the examination. Atypical bilateral pneumonitis, potentially suggestive of COVID involvement (moderate relaxation), with probable superinfection of bronchial origin within the left upper lobe. Introduction of levofloxacin. On 12Mar2021: clinical examination: patient is reactive Glasgow 3 with pupils in a reactive mydriasis, eye rolling; generalized mottling; grazing. Saturation at 82% AA (Amino Acids) increased to 95% on 15l oxygen. Lung auscultation: bilateral crackles. Emergency brain scan: systematized left frontal hypodensity suggesting an acute constituted ischemic focus. In view of the patient''s neurological condition and the severe cardiovascular terrain, it was decided to start palliative care. Dyspnoea, fever and ischaemic stroke the day after a D1 of COMIRNATY in a frail patient with a long cardiovascular history; COVID PCR (Polymerase chain reaction) negative but atypical lung lesions suggestive of moderate COVID involvement with probable bronchial superinfection. Outcome of dyspnoea, fever and ischaemic stroke was fatal while it was unknown for the other events. The patient died on 12Mar2021 at 14:30. Causes of death were reported as dyspnoea, fever and ischaemic stroke. It was unknown if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Dyspnoea; fever; ischaemic stroke


VAERS ID: 1146543 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-10
Onset:2021-02-18
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6795 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood culture, Body mass index, Body temperature, Bronchitis, C-reactive protein, COVID-19, Computerised tomogram thorax, Fall, Fibrin D dimer, Lymphocyte count, Lymphopenia, Oxygen saturation, Platelet count, SARS-CoV-2 test, Thrombocytopenia, Vaccination failure
SMQs:, Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Lack of efficacy/effect (narrow), Systemic lupus erythematosus (broad), Accidents and injuries (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ATORVASTATINE ARROW; NATISPRAY; XELEVIA; ELIQUIS; UVEDOSE; CATAPRESSAN [CLONIDINE HYDROCHLORIDE]; STAGID; ESCITALOPRAM ARROW; ESOMEPRAZOLE; LEVOTHYROX; KARDEGIC; AMIODARONE; ATACAND; ACEBUTOLOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cecity; Coronary arterial stent insertion; Fibrillation atrial; Hypertension arterial; Hypothyroidism; Ischaemic heart disease; Type II diabetes mellitus
Allergies:
Diagnostic Lab Data: Test Date: 20210223; Test Name: Blood cultures; Result Unstructured Data: Test Result:no -negative; Test Name: BMI; Result Unstructured Data: Test Result:27.4; Comments: BMI 27,4 kg/m2; Test Name: body temperature; Result Unstructured Data: Test Result:38.2 Centigrade; Test Date: 20210223; Test Name: body temperature; Result Unstructured Data: Test Result:38 Centigrade; Test Date: 20210301; Test Name: Chest CT scan; Result Unstructured Data: Test Result:multiple endobronchial secretions; Comments: Chest CT compatible with Covid-19 lung infection, moderate involvement (25-50%). Signs of associated bronchial superinfection.; Test Name: CRP; Result Unstructured Data: Test Result:39.6 mg/l; Test Date: 20210222; Test Name: CRP; Result Unstructured Data: Test Result:26.7 mg/l; Test Date: 20210223; Test Name: D-dimer; Result Unstructured Data: Test Result:1462 ng/ml; Test Date: 20210225; Test Name: D-dimer; Result Unstructured Data: Test Result:502 ng/ml; Test Date: 20210301; Test Name: D-dimer; Result Unstructured Data: Test Result:1462 ng/ml; Test Date: 20210303; Test Name: D-dimer; Result Unstructured Data: Test Result:1966 ng/ml; Test Date: 20210305; Test Name: D-dimer; Result Unstructured Data: Test Result:1095 ng/ml; Test Date: 20210222; Test Name: Lymphocytes; Result Unstructured Data: Test Result:0.74 g/l; Test Date: 20210301; Test Name: Lymphocytes; Result Unstructured Data: Test Result:0.57 g/l; Test Date: 20210303; Test Name: Lymphocytes; Result Unstructured Data: Test Result:0.82 g/l; Test Date: 20210305; Test Name: Lymphocytes; Result Unstructured Data: Test Result:0.93 g/l; Test Date: 20210223; Test Name: lymphopenia; Result Unstructured Data: Test Result:350 /mm3; Test Date: 20210223; Test Name: saturation; Test Result: 90 %; Comments: saturation room air 90%; Test Date: 20210222; Test Name: Platelets; Result Unstructured Data: Test Result:108 g/l; Test Date: 20210301; Test Name: Platelets; Result Unstructured Data: Test Result:198 g/l; Test Date: 20210303; Test Name: Platelets; Result Unstructured Data: Test Result:219 g/l; Test Date: 20210305; Test Name: Platelets; Result Unstructured Data: Test Result:188 g/l; Test Date: 20210211; Test Name: COVID-19 PCR; Result Unstructured Data: Test Result:no-negative; Test Date: 20210223; Test Name: COVID-19 PCR; Result Unstructured Data: Test Result:yes - positive; Test Date: 20210223; Test Name: thrombocytopenia; Result Unstructured Data: Test Result:100 g/l
CDC Split Type: FRPFIZER INC2021311882

Write-up: bronchial superinfection; Vaccination failure; Covid-19 infection confirmed by positive PCR; lymphopenia; thrombocytopenia; falls; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number FR-AFSSAPS-BX20211500. A 93-year-old male patient received his second dose of bnt162b2 (COMIRNATY; Lot Number: EJ6795), intramuscular on 10Feb2021 as single dose, and his first dose of bnt162b2 (COMIRNATY; Lot Number: EJ6795) intramuscular on 20Jan2021 as single dose for covid-19 immunisation, and acebutolol, via an unspecified route of administration from an unspecified date, at an unspecified dose and for an unspecified indication. The patient received the first dose of bnt162b2 (COMIRNATY; Lot Number: EJ6795) intramuscular on 20Jan2021 as single dose for covid-19 immunisationm. Medical history included type II diabetes mellitus, coronary arterial stent insertion, Ischaemic heart disease, cecity, hypertension arterial, fibrillation atrial and hypothyroidism. The patient was at high risk of severe COVID with fatal outcome. Patient resided in nursing home since Nov2020. BMI was 27,4 kg/m2. Concomitant medications included atorvastatin calcium (ATORVASTATINE ARROW), glyceryl trinitrate (NATISPRAY), sitagliptin phosphate (XELEVIA), apixaban (ELIQUIS), colecalciferol (UVEDOSE), clonidine hydrochloride (CATAPRESSAN), metformin embonate (STAGID), escitalopram oxalate (ESCITALOPRAM ARROW), esomeprazole, levothyroxine sodium (LEVOTHYROX), acetylsalicylate lysine (KARDEGIC), amiodarone (AMIODARONE) and candesartan cilexetil (ATACAND). The patient experienced vaccination failure with severe COVID-19 on 23Feb2021. No mention in the medical record of immediate post-vaccination effects. The patient had negative Polymerase Chain Reaction (PCR) on 11Feb2021. Repeated falls from 18Feb2021, with 2 emergency room visits (on 18Feb2021 and 22Feb2021), with hospitalization from 23Feb2021. After return to nursing home, new fall with presence of fever (38.2 Centigrade), bilateral crackles (present from 22Feb2021 with cough), desaturation with room air and inflammatory syndrome with CRP 39.6 mg/L (against 26.7 mg/L on 22Feb2021). On 23Feb2021 suspected vaccine failure with Covid-19 infection confirmed by positive PCR the same day, absence of specified variants. On admission, the patient had fever (38 Centigrade), saturation room air 90%, without alteration of consciousness, absence of painful complaints, bilateral and symmetrical vesicular murmur, bilateral crepitants of the bases with light predominance on the right, absence of dyspnea, signs of peripheral hypoxemia and mottles. Biological investigation on admission on 23Feb2021 showed lymphopenia (350/mm3) and thrombocytopenia (100 G/l), D-dimer 1462 ng/ml (reference value < 550 ng/ml). Initial management with amoxicillin/clavulanic acid then piperacillin/tazobactam from 01Mar2021, prednisone from 25Feb2021, worsening neurological condition with hypovigilance, diabetes de-equilibrium, hyperosmolar coma. Chest CT scan performed on 01Mar2021 showed presence of multiple endobronchial secretions, especially in the left basal pyramid, left stem bronchus. Thickening of the bronchial walls, diffuse bronchiectasis images, especially in the middle lobe, apical and dorsal segments of the right upper lobe. Mixed ground-glass infiltrate, peribroncho-vascular and subpleural, predominantly in the upper lobes, moderate involvement 25-50%. Chest CT was compatible with Covid-19 lung infection, moderate involvement (25-50%). Signs of associated bronchial superinfection. Blood cultures of 23Feb2021 was negative. The patient had unfavorable evolution with worsening of the neurological state, in spite of a control of glycemia, increase of pulmonary lesions of the COVID with death. The patient performed lab tests which included also lymphocytes (VN: 1.24-3.62 G/L): 0.74 (22Feb2021), 0.57 (01Mar2021), 0.82 (03Mar2021), 0.93 (05Mar2021); platelets (VN : 150-393 G/L): 108 (22Feb2021), 198 (01Mar2021), 219 (03Mar2021), 188 (05Mar2021); D-dimer (VN: 0-500 ng/mL): 1462 (25Feb2021), 1966 (01Mar2021), 1095 (03Mar2021), 502 (05Mar2021). The patient died on an unspecified date. It was not reported if an autopsy was performed. The outcome of events falls, lymphopenia, thrombocytopenia and bronchial superinfection was unknown. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Vaccination failure; Covid-19 infection confirmed by positive PCR


VAERS ID: 1146552 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-25
Onset:2021-03-01
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, COVID-19, Confusional state, Fall, Oxygen saturation, Oxygen saturation abnormal, SARS-CoV-2 test, Tachypnoea
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Eosinophilic pneumonia (broad), Respiratory failure (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-07
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: GLIMEPIRIDE; INDAPAMIDE;PERINDOPRIL; KARDEGIC; NEBIVOLOL; FOLIC ACID; ANASTROZOLE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Breast cancer; Diabetes; Essential thrombocythemia; Gastrointestinal stromal tumor; Heartburn; Osteoporosis; Partial gastrectomy; Vertebral collapse
Allergies:
Diagnostic Lab Data: Test Date: 20210304; Test Name: desaturation; Test Result: 89 %; Test Date: 20210304; Test Name: COVID-19 antigen test; Test Result: Positive
CDC Split Type: FRPFIZER INC2021311852

Write-up: COVID-19 RESPIRATORY INFECTION; ABNORMAL OXYGEN SATURATION; POLYPNOEA; MENTAL CONFUSION; FALL; ASTHENIA; This is a spontaneous report from contactable pharmacist downloaded from the regulatory authority-WEB. The regulatory authority report number is FR-AFSSAPS-LL20211120. An 86-year-old female patient received BNT162B2 (COMIRNATY, lot number and expiry date were unknown, unknown if 1st or 2nd dose), via intramuscular route on 25Feb2021 as a single dose for COVID-19 immunisation. Medical history included heartburn, GIST with partial gastrectomy, essential thrombocythemia, diabetes, breast cancer, osteoporosis with vertebral collapse. Concomitant medications included glimepiride 1 mg, indapamide/perindopril 2/0.625 mg, acetylsalicylate lysine (KARDEGIC 75 mg), nebivolol 2.5 mg/ day; folic acid 5 mg, anastrozole 1 mg/day. On 04Mar2021 7:00 p.m., the patient referred to the emergency department by her attending physician for polypnea, 89% desaturation in ambient air and confusion. According to the patient, asthenia and falls for about 3 days and diarrhea for 2 days (therefore date of onset of symptoms on 01Mar2021). COVID + Antigen test in the emergency room. On 05Mar2021, the patient was hospitalized in a COVID unit for COVID +. Medical treatment included O2 8L / min, lovenox 0.4 x 2 / day, Dexamethasone 6mg IV per day, antibiotic therapy for extensive pulmonary involvement: Cefotaxime and Rovamycin. On 06Mar2021, rapid deterioration of the patient''s state of health was reported. At 3h O2 15L / min, at 4 p.m. O2 30L / min. At 7 p.m., the patient''s vital prognosis was engaged, she received comfort care. On 07Mar2021 at 2 a.m., death of the patient was reported. Events were fatal. The cause of death was COVID19. NB: imputability without prejudice to the elements of investigation which could be carried out within the framework of legal or amicable compensation procedures. No follow-up attempts are possible, information on batch/ lot number cannot be obtained.; Reported Cause(s) of Death: COVID19


VAERS ID: 1149589 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-02-09
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Anaemia, Blood test, COVID-19, Drug ineffective, Lymphopenia, Renal failure, Renal function test, SARS-CoV-2 test, White blood cell count
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Haematopoietic erythropenia (broad), Haematopoietic leukopenia (narrow), Lack of efficacy/effect (narrow), Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-22
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: CANDESARTAN CILEXETIL; PRAVASTATIN SODIUM; PANTOPRAZOLE; MOVICOL [MACROGOL 4000;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE]; DOLIPRANE; HYDROCHLOROTHIAZIDE; PREDNISONE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic obstructive airways disease; Double inguinal hernia; Dupuytren''s contracture; Fracture, closed, colles'' (fracture Beam Glues left); Haemorrhoids; Hypercholesterolemia; Living in residential institution; Nasal polyps; Oesophagitis ulcerative (stage IV); Pleuritis; Pyelonephritis; Shoulder dislocation; Venous peripheral insufficiency (lower limbs)
Allergies:
Diagnostic Lab Data: Test Name: anemia; Result Unstructured Data: Test Result:11.6 g/dl; Test Name: clearance; Result Unstructured Data: Test Result:44.2 ml/min; Comments: stage 3 renal failure with a clearance of 44.2mL / min.; Test Date: 20210209; Test Name: PCR SarS-CoV-2; Test Result: Positive ; Test Name: lymphopenia; Result Unstructured Data: Test Result:0.93 g/l
CDC Split Type: FRPFIZER INC2021311770

Write-up: COVID-19 aggravated; COVID-19 aggravated; Anemia; Lymphopenia; Stage 3 renal failure; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB, regulatory authority number FR-AFSSAPS-AM20210581. A 100-year-old male patient living in a retirement home received first dose of bnt162b2 (COMIRNATY) intramuscular, administered in Deltoid Left on 21Jan2021 (Lot Number: EM0477) as single dose for covid-19 immunisation. Medical history included double inguinal hernia, fracture, closed, colles'' (fracture beam glues left), nasal polyps, venous peripheral insufficiency (lower limbs), haemorrhoids, oesophagitis ulcerative (stage IV), chronic obstructive airways disease, hypercholesterolaemia, pyelonephritis, dupuytren''s contracture, shoulder dislocation and pleuritis. Concomitant medications included candesartan cilexetil (CANDESARTAN CILEXETIL), pravastatin sodium (PRAVASTATIN SODIUM), pantoprazole (PANTOPRAZOLE), macrogol 4000, potassium chloride, sodium bicarbonate, sodium chloride (MOVICOL), paracetamol (DOLIPRANE), hydrochlorothiazide (HYDROCHLOROTHIAZIDE), prednisone (PREDNISONE). On 21Jan2021, the patient received his first injection of COMIRNATY. Four weeks after his vaccination, on 09Feb2021, in front of a pulmonary symptomatology, realization of a PCR SarS-CoV-2 which returned positive. Support was as follows: amoxicillin, clavulanic acid (AUGMENTIN) and levofloxacin (LOVENOX). On 16Feb2021, faced with the development of a severe form of COVID-19, he was hospitalized. The management was as follows: bi antibiotic therapy with ceftriaxone sodium (ROCEPHIN) and erythromycin, high flow oxygen therapy (12L/ min). No intensive care. On unknown date, on the laboratory assessment, anemia at 11.6g/ dL, lymphopenia at 0.93G/ L, stage 3 renal failure with a clearance of 44.2mL/ min. From 17Feb2021 to 22Feb2021 degradation of the patient requiring sedation. Patient died on 22Feb2021 due to COVID-19. An autopsy was not performed. Outcome of the events renal failure, lymphopenia and anemia was unknown. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Drug ineffective; Drug ineffective; COVID-19


VAERS ID: 1149874 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-24
Onset:2021-03-14
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6790 / 1 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test, SARS-CoV-2 test positive
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-16
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 molecular test; Result Unstructured Data: Test Result:positive; Test Name: rapid antigen swab; Result Unstructured Data: Test Result:positive
CDC Split Type: ITPFIZER INC2021323047

Write-up: After the 1st dose, the patient became ill with COVID-19.; After the 1st dose, the patient became ill with COVID-19.; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB IT-MINISAL02-703039. A 92-year-old male patient received the first dose of BNT162B2 (COMIRNATY; Lot Number: EJ6790; Expiration Date: 31Mar2021), intramuscular, administered on the right arm on 24Feb2021 as 0.3 mL, single for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 14Mar2021, following serious asthenia, the other healthcare professional was contacted and performed a rapid positive antigenic swab and transported to the emergency room where positivity was confirmed with a molecular test. In ER, bilateral interstitial pneumonia was diagnosed and death occurs on 16Mar2021. Therapeutic measures were taken as a result of the event. The patient died on 16Mar2021. It was not reported if an autopsy was performed. Reporter''s comment: Onset of Covid 19 with bilateral interstitial pneumonitis about 2 weeks after 1st vaccination.; Reporter''s Comments: Onset of Covid 19 with bilateral interstitial pneumonitis about 2 weeks after 1st vaccination.; Reported Cause(s) of Death: bilateral interstitial pneumonia; Covid-19


VAERS ID: 1151778 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-01
Onset:2021-03-17
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Lymphopenia, Thrombocytopenia
SMQs:, Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Lack of efficacy/effect (narrow), Systemic lupus erythematosus (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021328289

Write-up: Symptomatic Covid-19 Infection; Thrombopenia; Lymphopenia; Symptomatic Covid-19 Infection; This is a spontaneous report received from a non-contactable physician downloaded from the WEB. The regulatory authority report number is DE-PEI-PEI2021003640. An 88-year-old male patient received bnt162b2 (COMIRNATY), first dose via an unspecified route of administration on 01Mar2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that on 18-Mar-2021 after vaccination the patient developed COVID-19 (reported as Symptomatic Covid-19 Infection) and Lymphopenia and Thrombopenia, lasting for unknown. The patient is dead. Relatedness of drug to all event(s) assessed by PEI as Unclassifiable. The patient died on an unspecified date. It was not reported if an autopsy was performed. Information on lot and batch numbers cannot be obtained. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Symptomatic Covid-19 Infection; Lymphopenia; Thrombopenia; Symptomatic Covid-19 Infection


Result pages: prev   15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=24&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166